Charles‐Schoeman, C., DeMasi, R., Valdez, H., Soma, K., Hwang, L., Boy, M. G., . . . McInnes, I. B. (2019). Risk Factors for Major Adverse Cardiovascular Events in Phase III and Long‐Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis. Arthritis Rheumatol.

Charles‐Schoeman, Christina, Ryan DeMasi, Hernan Valdez, Koshika Soma, Lie‐Ju Hwang, Mary G. Boy, Pinaki Biswas, and Iain B. McInnes. "Risk Factors for Major Adverse Cardiovascular Events in Phase III and Long‐Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis." Arthritis Rheumatol 2019.

Charles‐Schoeman, Christina, et al. "Risk Factors for Major Adverse Cardiovascular Events in Phase III and Long‐Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis." Arthritis Rheumatol 2019.